Skip to content

Risk Factors for Anxiety and Depression Among Pregnant Women During the COVID-19 Pandemic

Risk Factors for Anxiety and Depression Among Pregnant Women During the COVID-19 Pandemic - a Web-based Cross-sectional Survey

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04377412
Acronym
MindCOVID
Enrollment
8500
Registered
2020-05-06
Start date
2020-05-01
Completion date
2020-10-31
Last updated
2020-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety, Depression, Pregnancy Related

Keywords

coronavirus, mental health, pregnancy, anxiety, depression, COVID-19, pandemic

Brief summary

The article presents a protocol of a cross-sectional study of mental health of pregnant women in relation to the COVID 19 pandemic. The primary aim is to compare differences in anxiety and depression scores of pregnant women between countries affected by the COVID-19 pandemic. The secondary aim is to assess demographic, economic, and social aspects affecting maternal anxiety and depression scores among pregnant women worldwide in the time of the COVID-19 pandemic. Finally, investigators will be able to compare differences in perception of the different aspects of the COVID-19 pandemic (social distancing, restrictions related to delivery) between countries and according to the epidemic status (number of infected patients, number of reported deaths). The comparisons will also be done according to COVID-19 status of the participants.

Interventions

OTHERPandemic control measures

Population of different countries are exposed to different pandemic control measures, and everyday lives of pregnant women are affected on different levels. Investigators will measure influence their influence on mental health.

Sponsors

University of Medicine, Tirana
CollaboratorOTHER
Royal Prince Alfred Hospital, Sydney, Australia
CollaboratorOTHER
Charles University, Czech Republic
CollaboratorOTHER
Hôpital Necker-Enfants Malades
CollaboratorOTHER
Charite University, Berlin, Germany
CollaboratorOTHER
Chinese University of Hong Kong
CollaboratorOTHER
Meir Medical Center
CollaboratorOTHER
Università degli Studi di Brescia
CollaboratorOTHER
American University of Beirut Medical Center
CollaboratorOTHER
Karolinska Institutet
CollaboratorOTHER
Pomeranian Medical University Szczecin
CollaboratorOTHER
Nicolaus Copernicus University
CollaboratorOTHER
Centre of Postgraduate Medical Education
CollaboratorOTHER
Polish Academy of Sciences
CollaboratorOTHER
Central Clinical Hospital of the Ministry of Internal Affairs and Administration, Warsaw, Poland
CollaboratorOTHER
Fundación Para la Investigación y el Desarrollode la Medicina Materno-Fetal y Neonatal iMaterna, Madrid
CollaboratorUNKNOWN
Taiji Clinic, Taipei
CollaboratorUNKNOWN
Wayne State University
CollaboratorOTHER
Chang Gung University
CollaboratorOTHER
University of Tromso
CollaboratorOTHER
Żelazna Medical Centre, LLC
Lead SponsorOTHER

Study design

Observational model
ECOLOGIC_OR_COMMUNITY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* declaration of being pregnant * being able to complete the survey in the available languages * answer the screening questions * provide informed consent for participation

Exclusion criteria

* not providing online informed consent for participation * if the participant does not click on the submit button at the end of the survey * not answer all the GAD-7 and PHQ-9 scale questions

Design outcomes

Primary

MeasureTime frameDescription
Anxiety4 monthsAnxiety measured by General Anxiety Disorder-7 (GAD-7) scale. Scoring:5-9 mild; 10-14 moderate; \>15 severe. Minimum 0, maximum 21 points
Depression4 monthsDepression measured by Patient Health Questionnaire-9 (PHQ-9) scale. Scoring: 5-9 mild;10-14 moderate; 15-19 moderately severe; \>20 severe. Minimum 0 maximum 27 points

Countries

Albania, Australia, Czechia, France, Germany, Hong Kong, Israel, Italy, Lebanon, Norway, Poland, Spain, Sweden, Taiwan, United States

Contacts

Primary ContactAnna Kajdy, MD, PhD
akajdy@cmkp.edu.pl+48663769515
Backup ContactDorota Sys, PhD
dsys@cmkp.edu.pl+48222559918

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 10, 2026